The FDA Approved a Video Game as Medicine: What Comes Next

#gaming #neuroscience #productivity #psychology

The FDA Approved a Video Game as Medicine: What Comes Next

There was a time when a doctor prescribing a video game would have been the punchline of a joke. Parents were told to pry controllers from their children's hands. Researchers warned of attention deficits, addiction, and social withdrawal. The cultural consensus was clear: screens were the problem, not the solution.

Then, on June 15, 2020, the FDA authorized the first video game as a medical treatment — and the punchline became a prescription.

EndeavorRx, developed by Akili Interactive and rooted in a decade of neuroscience research at UC San Francisco, crossed a threshold that few in the gaming world had dared imagine. It wasn't approved as a wellness app, a productivity tool, or a feel-good supplement. It was cleared as a digital therapeutic — the same regulatory category as medical devices — for children with ADHD. The era of prescription gaming had officially begun.

How a Racing Game Changed the Definition of Medicine

EndeavorRx looks, on the surface, like a perfectly ordinary mobile game. Players pilot a spacecraft through obstacle-filled terrain, collecting targets while avoiding distractions. But every pixel of that experience is engineered with clinical precision.

The game's design traces back to 2013, when Dr. Adam Gazzaley at UCSF published a landmark paper in Nature showing that a custom driving game called Neuroracer improved attention and cognitive control in older adults. The FDA's own review documents describe EndeavorRx as "engineered as a therapeutically active treatment for attention in pediatric patients affected by ADHD," built on Akili's proprietary interference-based cognitive training platform.

The clinical evidence was substantial. Across five clinical studies involving over 600 children with ADHD, EndeavorRx demonstrated consistent improvements in attention as measured by the Test of Variables of Attention (TOVA) — a validated neuropsychological instrument. EndeavorRx's published clinical data reports that 73% of children showed improvement in attention, and 68% of parents reported meaningful reductions in ADHD-related impairments after two months of treatment — with no serious adverse events across any trial.

The FDA authorized it as a de novo medical device: a prescription-only digital therapeutic, indicated for children aged 8–17, intended as an adjunct to — not a replacement for — existing treatment programs. The recommended dosage was approximately 25 minutes a day, five days a week.

That last detail is worth pausing on. The concept of a dosage for a video game — a regimen, a course of treatment, a prescription from a licensed clinician — represents something genuinely new in medicine.

The Science Behind the Screen

EndeavorRx's approval wasn't luck. It emerged from a growing body of research demonstrating that intentionally designed games can produce measurable, lasting changes in brain function. The neuroscience is built on a well-established principle: the brain remains plastic throughout life, and targeted, repetitive cognitive challenges can reshape neural networks.

Bonnechère et al.'s 2016 systematic review was one of the earliest rigorous compilations of this evidence, examining commercial video games in physical and cognitive rehabilitation across multiple pathologies. The finding — that games could function as a meaningful adjunct to traditional rehabilitation — laid the groundwork for the clinical frameworks that followed. Subsequent work has only expanded the scope.

Stroke rehabilitation is one of the best-documented areas. Systematic reviews have consistently found that video game-based therapy is at least as effective as conventional rehabilitation for upper limb motor recovery, and often superior in the critical first month post-stroke — largely because patients engage more deeply and sustain effort longer. The psychological factor matters: when patients focus on the game rather than their limitations, exercises become motivating rather than discouraging, driving the repetitive neural stimulation required for motor plasticity.

The mental health evidence is equally compelling. A 2021 narrative review published in JMIR Serious Games by Malhotra and Jain concluded that commercial video games show "great promise as inexpensive, readily accessible, internationally available, effective, and stigma-free resources for the mitigation of some mental health issues." The review specifically highlighted anxiety and depression — the two most prevalent mental health disorders — finding that certain game genres produced meaningful symptom reductions through mechanisms including cognitive distraction, emotional reappraisal, social connection, and the activation of reward and motivation circuits.

For PTSD, the evidence points strongly toward Virtual Reality Exposure Therapy (VRET). A 2024 clinical trial published in JAMA Psychiatry, conducted at the Providence Veterans Affairs Medical Center, found that VR exposure therapy combined with mild electrical brain stimulation produced significant, sustained reductions in PTSD symptom severity in military veterans — with effects continuing to build after the treatment period ended. The same outcomes that required 12 weeks through traditional prolonged exposure therapy were accelerated to two weeks with VR-assisted protocols.

The FDA, the research community, and the clinical establishment are no longer debating whether games can be medicine. The question is now: what does the next decade look like?

From ADHD to Everything: The Expanding Therapeutic Map

EndeavorRx opened a regulatory door, and others are moving through it. By mid-2025, the FDA had cleared 13 prescription digital therapeutics, targeting conditions from mental health to metabolic disorders — a category that barely existed five years ago.

The therapeutic gaming landscape now spans a remarkable range of conditions:

Cognitive decline and dementia: Digital therapeutics incorporating gamified cognitive tasks are being deployed for early intervention in Alzheimer's and age-related cognitive impairment. Platforms like CogniFit deliver personalized, adaptive training that has shown statistically significant improvements in cognitive function in older adults, according to a 2025 review in the Journal of Medical Internet Research. The adaptive algorithms — adjusting difficulty in real time based on performance — mirror the precision of pharmaceutical dosing.

Stroke and neurological rehabilitation: The 2023 Malaysian Journal of Medical Sciences systematic review of mobile game-based neurorehabilitation found consistent benefits across cognitive skills, memory, attention, executive function, motor functionality, balance, and visuospatial ability — representing essentially the full spectrum of post-stroke recovery targets.

Anxiety and depression: Clinical research demonstrates that purpose-built games leveraging cognitive behavioral therapy (CBT) principles can produce recovery rates in some populations that exceed traditional counseling. The SPARX study — a CBT-based RPG for adolescent depression — found that 44% of teen players fully recovered from depression, compared to 26% in regular treatment.

PTSD: VR-based exposure protocols are not just promising — they are being operationalized in clinical and VA settings today. At Wayne State University, AI-enhanced augmented reality therapy is being deployed specifically to address the real-world social and occupational avoidance patterns that standard PTSD treatments fail to reach.

The pattern across all of these conditions is consistent: games work best when they are adaptive, personalized, and integrated with existing care — not as a silver bullet, but as a powerful and scalable complement.

The Cognitive Training Revolution — and What's Being Built Now

The convergence of neuroscience and game design is no longer confined to research labs and clinical trials. Independent developers and neuroscience-driven studios are now building consumer-facing tools that translate this evidence into everyday life.

Altered Brilliance, built by Kri Zek, is one such application — a cognitive training tool designed from the ground up around the neurological mechanisms that EndeavorRx and its predecessors validated. Rather than generic "brain games," the architecture prioritizes sustained and selective attention, interference suppression, and adaptive challenge — the specific cognitive faculties that clinical research has shown are modifiable through targeted interactive training.

This matters because the gap between FDA-authorized therapeutics and consumer cognitive wellness tools is real but narrowing. EndeavorRx required years of clinical trials and a regulatory pathway suited for medical devices. But the underlying neuroscience — the interference-based training, the multitasking challenge design, the adaptive difficulty scaling — is available to any developer with the knowledge and commitment to implement it rigorously. The question is no longer whether the science works. It is whether the execution honors it.

The industry is at an inflection point. Just as the first approved statins did not just treat a handful of patients — they redefined how medicine thought about cardiovascular prevention — EndeavorRx's approval signals a paradigm shift in how we think about cognitive health. The tools that follow will not all require FDA clearance to be meaningful.

Where This Is Heading: Personalization, Prevention, and the Prescription of the Future

The trajectory of prescription gaming points toward four distinct frontiers:

Personalized cognitive training. The next generation of therapeutic games will use real-time biometric data — eye tracking, reaction time, EEG signals, even heart rate variability — to dynamically calibrate the therapeutic challenge. Rather than a fixed protocol, each session becomes a unique, data-driven intervention calibrated to the individual's current cognitive state.

VR therapy at clinical scale. Oxford VR's gameChangeVR system is already delivering fully automated CBT in immersive VR environments for patients with schizophrenia and mood disorders. As headset costs decline and the evidence base expands, VR-based mental health therapy prescribed directly by clinicians may become a standard component of psychiatric and neurological care within the decade.

Gaming as preventive medicine. The most significant frontier may not be treatment but prevention. Early cognitive training — beginning in childhood and maintained throughout adulthood — could potentially delay or mitigate the onset of age-related cognitive decline, reduce anxiety vulnerability, and build psychological resilience before conditions become clinical. The shift from reactive to proactive cognitive health care represents a transformation in medicine at least as significant as the shift from treating infections to preventing them.

Regulatory maturation. The FDA's de novo pathway, used for EndeavorRx, and the ISO's 2023 formal definition of "Digital Therapeutics" (ISO/TR 11147) signal that regulators are developing the frameworks to evaluate and authorize these tools rigorously. More prescription digital therapeutics will reach the market — not by lowering standards, but because the science is increasingly meeting them.

The Narrative Has Flipped

For decades, the story of gaming and health ran in one direction: warnings, moral panics, addiction studies, parental concern. The cultural narrative was that screens were something to be managed, limited, and feared.

That narrative has not disappeared — problematic gaming and screen overuse are real concerns that deserve serious attention. But it has been joined by a parallel and increasingly well-documented story: that games, when designed with intention and grounded in neuroscience, can do things that pills and talk therapy cannot easily replicate. They can be engaging where compliance with traditional treatment fails. They can reach patients who resist clinical settings. They can adapt to each individual in real time. And they can be deployed at scale, at low cost, across geographies and demographics that conventional care struggles to serve.

EndeavorRx was a proof of concept. The FDA's authorization was not just regulatory approval for one product — it was a signal to an entire industry that the evidence bar could be cleared, that the pathway exists, and that games can be held to the same standards of rigor as pharmaceuticals and medical devices.

The question for developers, clinicians, researchers, and patients is not whether gaming will have a permanent place in medicine. It already does. The question is how well we will build what comes next — and whether we will honor the science that made it possible.

If you want to explore what evidence-based cognitive training looks like outside the clinic, Altered Brilliance is available on Google Play. And if you want to follow the ongoing research and development behind The Power of Gaming, visit krizek.tech for the latest.

The prescription has been written. Now comes the real work.